Leap Year
Revolutionary therapies restructure pharmaceutical manufacturing.
Bridging Gaps and Investing in Change
European bio/pharma companies have no choice but to invest and adapt to the evolving industry needs.
New Therapies Cry Out for New Skills
There are positive indications for future growth.
Developing an Optimized Risk Assessment Portfolio—The Quality Risk Management Master Plan
A thoughtfully constructed QRM Master Plan translates the strategy and enables a risk-based approach.
Frontrunners in Molecular Glues
Novel molecular glues are transforming targeted protein degradation.
Choosing the Right Excipients for MSC and iPSC Therapies
Buffers, stabilizers, and cryoprotectants play major roles in cell therapy formulations.
Navigating Trends in Secondary Packaging
Designers adopt value-added features, different materials, and enhanced coding technologies.
Bringing Collaboration to the Horizon Once More
UK scientists are once again able to participate in the Horizon European research programme thanks to a deal struck in 2023.
Proving It’s Clean with Analytics
Analytical methods and tools play a pivotal role in cleaning validation.
Finalizing the European Health Data Space
The EHDS aims to increase access to health data, but how will it impact pharma?
Unlucky for Some
Clarivate has released its 2024 Drugs to Watch report, highlighting 13 therapies with great potential.
Reimbursement Precipitating Shortages
GSI shortages result from how hospitals buy GSI drugs, and the underinvestment in manufacturing operations that follow.
Are You Ready for Inspection?
Reviewing regulatory documents, such as 483 forms and Warning Letters, can aid in determining a facility’s inspection readiness, says Siegfried Schmitt, vice president, Technical at Parexel.
Pharmaceutical Testing Services
Galbraith Laboratories, a Bureau Veritas Company, offers a full range of analytical services for pharma, from R&D to final release testing.
Trial Rental Program for R&D Scale Equipment
ROSS Mixers, a provider of US-designed and manufactured mixing equipment, offers a Trial Rental Program, giving process managers an opportunity to optimize R&D projects before committing to a substantial investment.